MARKET

JNJ

JNJ

Johnson & Johnson
NYSE

Real-time Quotes | Nasdaq Last Sale

173.94
-1.56
-0.89%
After Hours: 173.76 -0.18 -0.10% 16:35 05/19 EDT
OPEN
174.72
PREV CLOSE
175.50
HIGH
174.80
LOW
172.69
VOLUME
6.87M
TURNOVER
0
52 WEEK HIGH
186.69
52 WEEK LOW
154.86
MARKET CAP
457.71B
P/E (TTM)
23.43
1D
5D
1M
3M
1Y
5Y
COVID SCIENCE-Vaccination after infection may curb long COVID; desktop 'air curtains' may deflect virus particles
reuters.com · 3h ago
What Are Whales Doing With Johnson & Johnson
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Benzinga · 7h ago
J&J touts Tremfya in-vitro studies differentiating it from AbbVie's Skyrizi
Johnson & Johnson's (NYSE:JNJ) Janssen unit said that new in-vitro data indicates that Tremfya (guyselkumab) can bind to both CD64 positive (CD64+) cells as well as interleukin (IL)-23. Janssen noted that
Seekingalpha · 8h ago
UPDATE 1-India supplies non-J&J COVID shots under Quad umbrella
India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries, New Delhi said on Thursday, though not the Johnson & Johnson shot as originally planned. The leaders of the Quad countries - India, the Unite...
Reuters · 9h ago
5 Reasons Why You Should Add Halozyme (HALO) to Your Portfolio
We provide five reasons, which make Halozyme (HALO) a good investment option in 2022.
Zacks · 9h ago
12 Best DOW Stocks To Buy According To Hedge Funds
In this article, we will discuss the 12 best DOW stocks to buy according to hedge funds. If you want to explore similar stock options, you can also take a look at 5 Best DOW Stocks To Buy According To Hedge Funds. The Dow Jones Industrial Average is a pric...
Insider Monkey · 10h ago
India has supplied COVID vaccines under Quad umbrella
reuters.com · 10h ago
WHO clears COVID vaccine by China's CanSino Biologics for emergency use
reuters.com · 11h ago
More
No Data
Learn about the latest financial forecast of JNJ. Analyze the recent business situations of Johnson & Johnson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

21.05%Strong Buy
31.58%Buy
47.37%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average JNJ stock price target is 190.67 with a high estimate of 215.00 and a low estimate of 173.00.
High215.00
Average190.67
Low173.00
Current 173.94
EPS
Actual
Estimate
0.671.332.002.67
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 4.35K
Institutional Holdings: 1.96B
% Owned: 74.45%
Shares Outstanding: 2.63B
TypeInstitutionsShares
Increased
1.51K
45.91M
New
383
10.99M
Decreased
1.31K
44.42M
Sold Out
83
3.36M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.15%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Chairman/Executive Director
Alex Gorsky
Chief Executive Officer/Director
Joaquin Duato
Chief Financial Officer/Executive Vice President
Joseph Wolk
Chief Human Resource Officer/Executive Vice President
Peter Fasolo
Executive Vice President/Chief Information Officer
James Swanson
Executive Vice President/General Counsel
Michael Ullmann
Executive Vice President
Vanessa Broadhurst
Executive Vice President
William Hait
Executive Vice President
Mathai Mammen
Executive Vice President
Ashley Mcevoy
Executive Vice President
Thibaut Mongon
Executive Vice President
Jennifer Taubert
Executive Vice President
Kathryn Wengel
Lead Director/Independent Director
Anne Mulcahy
Independent Director
Darius Adamczyk
Independent Director
Mary Beckerle
Independent Director
D. Scott Davis
Independent Director
Ian Davis
Independent Director
Jennifer Doudna
Independent Director
Marillyn Hewson
Independent Director
Hubert Joly
Independent Director
Mark Mcclellan
Independent Director
A. Eugene Washington
Independent Director
Mark Weinberger
Independent Director
Nadja West
No Data
No Data
About JNJ
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.

Webull offers kinds of Johnson & Johnson stock information, including NYSE:JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.